Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: An RCT

Human Reproduction

Volumn 31, Issue 9, 2016, Pages 2005-2016

  Dreyer, K ^a   Lier, M C I ^a   Emanuel, M H ^b   Twisk, J W R ^a   Mol, B W J ^c   Schats, R ^a   Hompes, P G A ^a   Mijatovic, V ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Essurew device; Hydrosalpinges; IVF; Pregnancy outcome; Salpingectomy; Tubal infertility

Indexed keywords

ANTIBIOTIC AGENT; CONTRAST MEDIUM; MUELLERIAN INHIBITING FACTOR;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTRAL FOLLICLE COUNT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; EMBRYO TRANSFER; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FETUS ECHOGRAPHY; GENERAL ANESTHESIA; HUMAN; HYDROSALPINX; HYSTEROSALPINGOGRAPHY; HYSTEROSCOPIC PROXIMAL TUBAL OCCLUSION; HYSTEROSCOPY; INTRACYTOPLASMIC SPERM INJECTION; LAPAROSCOPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; OPERATION DURATION; OUTCOME ASSESSMENT; OVARIAN RESERVE; PELVIC INFLAMMATORY DISEASE; PERITONEUM ADHESION; POSTOPERATIVE INFECTION; PREGNANCY OUTCOME; PREGNANCY RATE; PROXIMAL TUBAL LIGATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; SALPINGECTOMY; TUBAL OCCLUSION INSERT; UTERINE TUBE LIGATION; UTERINE TUBE SURGERY; VISUAL ANALOG SCALE; ADOLESCENT; DIAGNOSTIC IMAGING; IN VITRO FERTILIZATION; PREGNANCY; PROCEDURES; TREATMENT OUTCOME; UTERINE TUBE DISEASE; UTERINE TUBE STERILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; FALLOPIAN TUBE DISEASES; FEMALE; FERTILIZATION IN VITRO; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; SALPINGECTOMY; SPERM INJECTIONS, INTRACYTOPLASMIC; STERILIZATION, TUBAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84988976734     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dew050     Document Type: Article

References (39)

1. ACOG. ACOG Committee Opinion No. 458: Hysterosalpingography after tubal sterilization. Obstet Gynecol 2010; 115: 1343-1345.
2. Andersen AN, Yue Z, Meng FJ, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod 1994; 9: 1935-1938.
3. Arora P, Arora RS, Cahill D. Essure((R)) for management of hydrosalpinx prior to in vitro fertilisation-A systematic review and pooled analysis. BJOG 2014; 121: 527-536.
4. Bettocchi S. New era of office hysteroscopy. J Am Assoc Gynecol Laparosc 1996; 3: S4.
5. Daftary GS, Kayisli U, Seli E, Bukulmez O, Arici A, Taylor HS. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. Fertil Steril 2007; 87: 367-372.
6. Dechaud H, Daures JP, Arnal F, Humeau C, Hedon B. Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study. Fertil Steril 1998; 69: 1020-1025.
7. de Wit W, Gowrising CJ, Kuik DJ, Lens JW, Schats R. Only hydrosalpinges visible on ultrasound are associated with reduced implantation and pregnancy rates after in-vitro fertilization.HumReprod 1998; 13: 1696-1701.
8. Donaghay M, Lessey BA. Uterine receptivity: Alterations associated with benign gynecological disease. Semin Reprod Med 2007; 25: 461-475.
9. Galen DI, Khan N, Richter KS. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. J Minim Invasive Gynecol 2011; 18: 338-342.
10. Gelbaya TA, Nardo LG, Fitzgerald CT, Horne G, Brison DR, Lieberman BA. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertil Steril 2006; 85: 1464-1468.
11. Goldstein DB, Sasaran LH, Stadtmauer L, Popa R. Selective salpingostomy-salpingectomy and medical treatment prior to IVF in patients with hydrosalpinx. Fertil Steril 1998; 70: S320.
12. Hammadieh N, Coomarasamy A, Ola B, Papaioannou S, Afnan M, Sharif K. Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: A randomized controlled trial. Hum Reprod 2008; 23: 1113-1117.
13. Hitkari JA, Singh SS, Shapiro HM, Leyland N. Essure treatment of hydrosalpinges. Fertil Steril 2007; 88: 1663-1666.
14. Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, Coulson C, Lambert PA, Watt EM, Desai KM. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291: 1693-1697.
15. Hurskainen R, Hovi SL, Gissler M, Grahn R, Kukkonen-Harjula K, Nord-Saari M, Makela M. Hysteroscopic tubal sterilization: A systematic review of the Essure system. Fertil Steril 2010; 94: 16-19.
16. Inocencio G, Coutinho L, Maciel R, Barreiro M. Pregnancy after hydrosalpinx treatment with Essure. BMJ Case Rep 2013; 2013.
17. Johnson N, van Voorst S, Sowter MC, Strandell A, Mol BW. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2010; CD002125.
18. Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglou E, Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril 2006; 86: 1642-1649.
19. Lass A, Ellenbogen A, Croucher C, Trew G, Margara R, Becattini C, Winston RM. Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program. Fertil Steril 1998; 70: 1035-1038.
20. Lu S, Peng H, Zhang H, Zhang L, Cao Q, Li R, Zhang Y, Yan L, Duan E, Qiao J. Excessive intrauterine fluid cause aberrant implantation and pregnancy outcome in mice. PLoS One 2013; 8: E78446.
21. Matorras R, Rabanal A, Prieto B, Diez S, Brouard I, Mendoza R, Exposito A. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Eur J Obstet Gynecol Reprod Biol 2013; 169: 54-59.
22. Mijatovic V, Veersema S, Emanuel MH, Schats R, Hompes PGA. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril 2010; 93: 1338-1342.
23. Mijatovic V, Dreyer K, Emanuel MH, Schats R, Hompes PGA. Essure(R) hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy. Eur J Obstet Gynecol Reprod Biol 2012; 161: 42-45.
24. Moshin V, Hotineanu A. Reproductive outcome of the proximal tubal occlusion prior to IVF in patients with hydrosalpinx. Hum Reprod 2006; 21(suppl 1): I193-i194.
25. Mukherjee T, Copperman AB, McCaffrey C, Cook CA, Bustillo M, Obasaju MF. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: A case for prophylactic salpingectomy. Fertil Steril 1996; 66: 851-853.
26. Ni L, Sadiq S,MaoY, CuiY,WangW, Liu J. Influence of various tubal surgeries to serum antimullerian hormone level and outcome of the subsequent IVF-ET treatment. Gynecol Endocrinol 2013; 29: 345-349.
27. OmurtagK, Pauli S, SessionD. Spontaneous intrauterine pregnancy after unilateral placement of tubal occlusive microinsert. Fertil Steril 2009; 92: 393-397.
28. Ouzounelli M, Reaven NL. Essure hysteroscopic sterilization versus interval laparoscopic bilateral tubal ligation: A comparative effectiveness review. J Minim Invasive Gynecol 2015; 22: 342-352.
29. Ozgur K, Bulut H, Berkkanoglu M, Coetzee K, Kaya G. ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients. Reprod Biomed Online 2014; 29: 113-118.
30. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG. Reporting of noninferiority and equivalence randomized trials: Extension of the CONSORT 2010 statement. JAMA 2012; 308: 2594-2604.
31. Rosenfield RB, Stones RE,Coates A, Matteri RK, Hesla JS. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertil Steril 2005; 83: 1547-1550.
32. StrandellA, LindhardA,WaldenstromU, Thorburn J, Janson PO,Hamberger L. Hydrosalpinx and IVFoutcome: A prospective, randomizedmulticentre trial in Scandinavia on salpingectomy prior to IVF.HumReprod 1999; 14: 2762-2769.
33. Strandell A, Lindhard A, Waldenstrom U, Thorburn J. Prophylactic salpingectomy does not impair the ovarian response in IVF treatment. Hum Reprod 2001; 16: 1135-1139.
34. Thebault N, Broux PL, Moy L, Vialard J. [Utilization of Essure(R) micro-insert for hydrosalpynx occlusion in infertile women]. J Gynecol Obstet Biol Reprod (Paris) 2012; 41: 145-150.
35. van Disseldorp J, Lambalk CB, Kwee J, Looman CW, Eijkemans MJ, Fauser BC, Broekmans FJ. Comparison of inter-And intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod 2010; 25: 221-227.
36. Veersema S, Vleugels MP, Timmermans A, Brolmann HA. Follow-up of successful bilateral placement of Essure microinserts with ultrasound. Fertil Steril 2005; 84: 1733-1736.
37. Wilkes S, Chinn DJ, Murdoch A, Rubin G. Epidemiology and management of infertility: A population-based study in UK primary care. Fam Pract 2009; 26: 269-274.
38. Ye XP, Yang YZ, Sun XX. A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve. Am J Obstet Gynecol 2015; 212: 53.e1-53.e10.
39. Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril 1998; 70: 492-499.